Comment on

• A national analysis of wedge resection versus stereotactic body radiation therapy for stage IA non-small cell lung cancer.

  Yerokun BA, Yang CJ, Gulack BC, Li X, Mulvihill MS, Gu L, Wang X, Harpole DH, D'Amico TA, Berry MF, Hartwig MG. Yerokun BA, et al. J Thorac Cardiovasc Surg. 2017 Aug;154(2):675-686.e4. doi: 10.1016/j.jtcvs.2017.02.065. Epub 2017 Apr 4. J Thorac Cardiovasc Surg. 2017. PMID: 28461054
• The slippery slope of nonoperative therapy in early-stage lung cancer.

  Schaheen LW, D'Cunha J. Schaheen LW, et al. J Thorac Cardiovasc Surg. 2017 Sep;154(3):1121-1122. doi: 10.1016/j.jtcvs.2017.06.009. Epub 2017 Jun 10. J Thorac Cardiovasc Surg. 2017. PMID: 28728786 No abstract available.
• The value of collaboration between thoracic surgeons and radiation oncologists while awaiting evidence in operable stage i non-small cell lung cancer.

  Moghanaki D, Simone CB 2nd, Rimner A, Karas TZ, Donington J, Shirvani SM, Daly M, Videtic GM, Movsas B; ASTRO Evidence-Based Guideline Committee for Stereotactic Body Radiation Therapy (SBRT) for Early-Stage Non–Small Cell Lung Cancer. Moghanaki D, et al. J Thorac Cardiovasc Surg. 2018 Jan;155(1):429-431. doi: 10.1016/j.jtcvs.2017.09.001. J Thorac Cardiovasc Surg. 2018. PMID: 29245205 No abstract available.
• Medical operability and inoperability drive survival in retrospective analyses comparing surgery and SBRT for early-stage lung cancer.

  Rusthoven CG, Jones BL, Kavanagh BD. Rusthoven CG, et al. J Thorac Cardiovasc Surg. 2018 Feb;155(2):810-811. doi: 10.1016/j.jtcvs.2017.09.087. J Thorac Cardiovasc Surg. 2018. PMID: 29415393 No abstract available.